AMERICA'S #1 OPHTHALMIC PHARMACY
Live / Registered — Registered (as of 25 Jun 2024)
What this means for you
Registered since 25 Jun 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Jun 2030: the §8 declaration of use).
Record
- Serial number
- 97525916
- Registration number
- 7430568
- Mark type
- Slogan / phrase
- Filed
- 29 Jul 2022
- Registered
- 25 Jun 2024
- Next maintenance filing
- §8 declaration of use, due by 25 Jun 2030 (grace period to 25 Dec 2030)
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 044 — Medical, beauty and agricultural services: Internet-based health care information services; telemedicine services; providing health care information by telephone and the internet; web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; health care services, namely, providing a database in the field of eye health care information that features data and information all for treatment and diagnostic purposes; health screening in the field of ophthalmic services
Owner
- Harrow IP, LLC, Nashville, TN, US
- Harrow IP, LLC, Nashville, TN, US
Prosecution history
- 25 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Jun 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 23 May 2024 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 22 May 2024 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 22 May 2024 — USE AMENDMENT ACCEPTED
- 20 May 2024 — AMENDMENT TO USE PROCESSING COMPLETE
- 31 Jan 2024 — USE AMENDMENT FILED
- 20 May 2024 — ASSIGNED TO LIE
- 20 May 2024 — ASSIGNED TO LIE
- 28 Feb 2024 — EXAMINER'S AMENDMENT ENTERED
- 28 Feb 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 28 Feb 2024 — EXAMINERS AMENDMENT E-MAILED
- 28 Feb 2024 — EXAMINERS AMENDMENT -WRITTEN
- 31 Jan 2024 — TEAS AMENDMENT OF USE RECEIVED
- 31 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED